Capstone Asset Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
HM
Capstone Asset Management's HAE Position: Q2 2017 in Review
Capstone Asset Management reduced its Haemonetics (HAE) stake by 9.2% in Q2 2017, selling an estimated $39.4K and leaving 9,499 shares worth $375K. The position accounts for 0.01% of the portfolio, ranked #1096.
Capstone Asset Management first reported a position in HAE in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.15M in Q2 2013. 197 funds tracked by Wall St. Rank hold HAE as of Q2 2017.
- Capstone Asset Management held 9,499 shares of Haemonetics worth $375K as of Q2 2017.
- Capstone Asset Management sold 960 Haemonetics shares in Q2 2017, an estimated $39.4K.
- Haemonetics made up 0.01% of Capstone Asset Management's portfolio in Q2 2017, its #1096 holding.
- Capstone Asset Management first reported a position in Haemonetics in Q2 2013 and has held it in 17 quarters since.
- Capstone Asset Management's Haemonetics position peaked at $1.15M in Q2 2013.
- 197 funds tracked by Wall St. Rank held Haemonetics as of Q2 2017.
Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.